Biologically important peptides
A | Angiotensin-III | |
B |
Angiotensin-IV |
|
C |
Angiotensin-II |
|
D |
Angiotensin-I |
Shortest peptide. is:
A |
Angiotensin-III |
|
B |
Angiotensin-IV |
|
C |
Angiotensin-II |
|
D |
Angiotensin-I |
Correct Ans–> Angiotensin-III & IV
- A decapeptide has ten amino acids (e.g., gonadotropin-releasing hormone & angiotensin I)., Angiotensin I officially called proangiotensin, is formed by the action of renin on angiotensinogen.
- Angiotensin I –> Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu | Val-Ile-..
- IT is converted to angiotensin II (AII) through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE), An octapeptide has eight amino acids (e.g., angiotensin II).,primarily through ACE within the lung (but also present in endothelial cells, kidney epithelial cells, and the brain).
- Angiotensin II ( Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) is degraded to angiotensin III by angiotensinases located in red blood cells and the vascular beds of most tissues.
- Angiotensin III –> Asp | Arg-Val-Tyr-Ile-His-Pro-Phe
- Angiotensin III has 40% of the pressor activity of angiotensin II, but 100% of the aldosterone-producing activity. Increases mean arterial pressure. It is a peptide that is formed by removing an amino acid from angiotensin II by aminopeptidase A
- It has a half-life in circulation of around 30 seconds, whereas, in tissue, it may be as long as 15–30 minutes.
- Angiotensin IV –> Arg | Val-Tyr-Ile-His-Pro-Phe
- It is a hexapeptide that, like angiotensin III, has some lesser activity. Angiotensin IV has a wide range of activities in the central nervous system.
So to conclude this Angiotensin III & IV is right answer
- Angiotensin-(3-4) (Ang-(3-4) or Val-Tyr) is the shorter angiotensin (Ang) II-derived peptide, formed through successive hydrolysis that culminates with the release of Val-Tyr as a dipeptide. It is formed both in plasma and in kidney from Ang II and Ang III, and can be considered a component of the systemic and organ-based renin-angiotensin system. It is potently antihypertensive in humans and rats, and its concerted actions on proximal tubule cells culminate in the inhibition of fluid reabsorption, hyperosmotic urinary excretion of Na+. At the renal cell signaling level, Ang-(3-4) counteracts Ang II-type 1 receptor-mediated responses by acting as an allosteric enhancer in Ang II-type 2 receptor populations that target adenosine triphosphate-dependent Ca2+ and Na+ transporters through a cyclic adenosine monophosphate-activated protein kinase pathway.
A |
Growth hormone |
|
B |
Insulin |
|
C |
PTH |
|
D |
Glucocorticoids |
Ans. is ‘d’ i.e., Glucocorticoids
Glucocorticoids are a class of corticosteroids, which are a class of steroid hormones. Glucocorticoids are corticosteroids that bind to the glucocorticoid receptor that is present in almost every vertebrate animal cell.
Bond involved in formation of primary structure of protein/polypeptide ‑
A |
Hydrogen |
|
B |
Peptide |
|
C |
Disulfide |
|
D |
A and B both |
Ans: D. A and B both
Bonds of Primary structure: Covalent bond i.e. Peptide bond
Features Of Peptide Bond:
- It is Trans in configuration
- It is neither completely single bond nor completely double bond, it is a Partial double bond
- It is Polar.
- It is Uncharged
- It is a Planar.
- CO-NH is going to be in one plane (2D )and the R and H group will be protruding outside.
A |
Topoisomerase |
|
B |
Transformylase |
|
C |
RNA polymerase |
|
D |
Peptidyl transferase |
Ans. ‘B’ Transformylase
Steps in eukaryotic translation (protein synthesis)
There are three major steps, in protein synthesis (translation):- (i) Initiation, (ii) Elongation; and (iii) Termination.
- In prokaryotes and in mitochondria, the first amino acid methionine is modified by formylation, i.e. the initiator tRNA carries an N-formylated methionine. The formyl group is added by the enzyme transformylase (formyl-transferase).
- In Eukaryotes, the initiator tRNA carries a methionine that is not formylated.
All the following are peptide based except ‑
A | ACTH | |
B | GnRH | |
C |
Thyroxin |
|
D |
TRH |
Ans. is ‘c’ i.e., Thyroxin
True about peptide bond formation:
A |
The NH2 group of new aminoacyl t -RNA at A site combine with the – COOH group of Met-t -RNA occupying the ‘P’ site |
|
B |
The NH2 group of new aminoacyl t – RNA at ‘P’ site combine with the – COOH group of Met-t-RNA occupying the ‘A site |
|
C |
Reaction is catalyzed by peptidyl transferase |
|
D |
Peptide bond formation require energy |
Ans: a. The NH2 and c. Reaction…[Ref Harper 30th/422-25, 28th/359-66; Lippincott 4th/438-42; Chatterjea te• Shinde 7th/248-501]
- The a-amino group of the new aminoacyl-tRNA in the A site carries out a nucleophilic attack on the esterified carboxyl group of the peptidyl-tRNA occupying the P site (peptidyl or polypeptide site). At initiation, this site is occupied by aminoacyl-tRNA met’.
- This reaction is catalyzed by a peptidyltransferase, a component of the 28S RNA of the 60S ribosomal subunit. This is another example of ribozyme activity and indicates an important—and previously unsuspected—direct role for RNA in protein synthesis.
- Because the amino acid on the aminoacyl-tRNA is already “activator no further energy source is required for this reaction. The reaction results in attachment of the growing peptide chain to the tRNA in the A site.